Markets
NextCure, Inc. (NXTC)
NXTCNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$6.29
-0.4130 (-6.16%) today
At the close, Nov 18, 4:00 PM ET. After hours $6.29 -8.69%
-6.16% 1D
- Market cap
- $31.53m
- P/E
- –
- EPS, last 4 quarters
- $-6.19
- Dividend yield
- –
- Day range
- $6.38 to $7.02
- 52-week range
- $1.55 to $15.74
- Average volume
- –
- Previous close
- $6.70
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Gross profit | – | – | – | – |
| Operating income | -$9.76m | -$10.11m | -$15.09m | -$6.92m |
| Net income | -$9.44m | -$9.80m | -$14.89m | -$6.85m |
The company
NextCure is a biopharmaceutical company focused on managing its legacy clinical and intellectual property assets, pursuing opportunities to maximize those legacy assets, fulfilling ongoing obligations under its existing collaboration and licensing agreements and advancing completion of the Merger with Avere.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- nextcure.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.